Liquidia Corporation (NASDAQ:LQDA) Q3 2023 Earnings Call Transcript

Julian Harrison: Very helpful. Thank you.

Roger Jeffs: Thanks for your question Julian. Operator, next question?

Operator: I am showing no further questions at this time. So, I would like to turn it back to Roger Jeffs.

Roger Jeffs: Thank you, Therese. So, I intentionally let the team answer most of the call today because I wanted the investors to hear the depth and quality of the team that we have that are ready and very excited about launching YUTREPIA in the very near future. The other thing you can hear is the quality of YUTREPIA’s product profile and its potential to quickly differentiate and become the prostacyclin of first choice as was asked about. We thank you for joining us today and we look forward to continuing to update you on our progress as we bridge to these important inflecting events. Thank you.

Operator: This does conclude the program. You may now disconnect.